Commerzbank Ag Analysts Give Bayer AG (BAYN) a €124.00 Price Target
A number of other equities research analysts also recently weighed in on the company. Sanford C. Bernstein set a €126.00 ($148.24) price objective on Bayer AG and gave the company a buy rating in a report on Friday. Citigroup Inc. set a €130.00 ($152.94) price objective on Bayer AG and gave the company a buy rating in a report on Thursday. Warburg Research set a €121.00 ($142.35) price objective on Bayer AG and gave the company a neutral rating in a report on Thursday. Independent Research GmbH set a €120.00 ($141.18) price objective on Bayer AG and gave the company a neutral rating in a report on Wednesday, October 4th. Finally, Baader Bank set a €140.00 ($164.71) price objective on Bayer AG and gave the company a buy rating in a report on Thursday, September 28th. Eight research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. The company has a consensus rating of Buy and a consensus price target of €121.55 ($142.99).
Shares of Bayer AG (FRA:BAYN) opened at 116.85 on Friday. The firm has a market capitalization of €101.91 billion and a PE ratio of 20.21. The stock’s 50 day moving average price is €110.38 and its 200-day moving average price is €111.88. Bayer AG has a 12 month low of €85.72 and a 12 month high of €123.82.
ILLEGAL ACTIVITY WARNING: “Commerzbank Ag Analysts Give Bayer AG (BAYN) a €124.00 Price Target” was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another website, it was illegally stolen and reposted in violation of US and international trademark & copyright legislation. The original version of this piece of content can be read at https://www.thecerbatgem.com/2017/10/09/commerzbank-ag-analysts-give-bayer-ag-bayn-a-124-00-price-target.html.
About Bayer AG
Receive News & Stock Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related stocks with our FREE daily email newsletter.